disclosures
play

Disclosures I have no conflicts of interest or relevant financial - PDF document

Oct 24, 2022 •237 likes •1.04k views

Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Hastening Death by Voluntarily Stopping Eating and Drinking: Legal Perspective Seattle University Oct. 14, 2016 Thaddeus Mason Pope, JD, PhD

  1. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Hastening Death by Voluntarily Stopping Eating and Drinking: Legal Perspective Seattle University • Oct. 14, 2016 Thaddeus Mason Pope, JD, PhD Mitchell Hamline School of Law Disclosures I have no conflicts of interest or relevant financial interests. 1

  2. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts 25 min Learning Objectives 2

  3. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Describe four legal foundations of a patient’s right to contemporaneous VSED Understand the challenges and risks for families and clinicians in implementing an advance VSED decision for a now incapacitated patient Compare legal distinctions between VSED, on the one hand, and medical aid in dying and withholding or withdrawing life- sustaining treatments, on the other hand Definition VSED 3

  4. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Physiologically able to take food & fluid by mouth 4

  5. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Voluntary, deliberate decision to stop Intent: death from dehydration 5

  6. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts >50% at 8d >80% at 14d Legal concerns Legal analysis 6

  7. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Legal concerns Uncertainty & reluctance among providers 7

  8. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Prohibited Unsure Permitted Almost never: express prohibition Legal & ethical expert support nearly universal 8

  9. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts RCWA specifically & expressly prohibits lots of things Not VSED BUT Absence of a red light not good enough 9

  10. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Clinicians want express permission No green light from Olympia 10

  11. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts No green light anywhere 11

  12. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Little precedent & not supportive No red lights No green lights Lack of clarity & guidance 12

  13. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Cinderalla pic again neglected in academic & policy circles 13

  14. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Providers still ask Is VSED legal? 14

  15. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Is VSED illegal? Wrong questions 15

  16. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Law is rarely binary Risk assessment 16

  17. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Measure Mitigate Legal analysis 17

  18. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts case types 18

  19. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts VSED now with capacity Ability to understand significant benefits, risks & alternatives Ability to make & communicate decision 19

  20. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Advance directive for VSED later (when lack capacity) 20

  21. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Patient with capacity requests VSED now Extremely low risk of sanctions – criminal, civil, regulatory 21

  22. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Right to refuse medical interventions 22

  23. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Right to refuse non -medical interventions Not assisted suicide 23

  24. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Not elder neglect 24

  25. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Right to refuse medical interventions Well established > 3 decades 25

  26. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts “A competent patient may refuse treatment . . .” Right to refuse medical 26

  27. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Vent Dialysis CPR Antibiotics Feed tube VSED Vent Dialysis CPR Antibiotics Feed tube 27

  28. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Cinderalla pic again ICD Vent Dialysis CPR Antibiotics Feed tube 28

  29. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts VSED Vent Dialysis CPR Antibiotics Feed tube Not DTC Not DIY 29

  30. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Contrast VSED 30

  31. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Part of a broader treatment plan Supervised by licensed healthcare professionals 31

  32. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts “the number of cases will increase. Since the concept of fasting is not taught in medical schools, we will produce a guide to support doctors.” Harvard CEC 32

  33. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts PAVSED “Palliated and Assisted Voluntarily Stopping Eating and Drinking” PAVSED Highlights medical role in palliating symptoms Highlights the direct care staff role in providing assistance 33

  34. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Medical b/c not “typical human” 34

  35. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts treatment 35

  36. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts unwanted Does not matter whether food & fluid are “medical treatment” 36

  37. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts “The common law right to be free from bodily invasion is an alternative basis ...” Battery 37

  38. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Unwanted contact Even if clinically beneficial 38

  39. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts “Every human being of adult years and sound mind has a right to determine what shall be done with his own body . . . . ” Patient Physician consented operated to left ear on right ear Mohr v. Williams (Minn. 1905) 39

  40. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Force feeding is a battery “It seems odd that your bodily integrity is [not] violated . . . by sticking a spoon in your mouth.” 40

  41. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Move now from legal bases, grounds for right Responding to main objections 41

  42. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts VSED is not assisted suicide 42

  43. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Alleged risk RCWA 9A.36.060 (1) A person is guilty of promoting a suicide attempt when he or she knowingly causes or aids another person to attempt suicide. (2) Promoting a suicide attempt is a class C felony. 43

  44. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Active Passive 44

  45. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts 45

  46. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts VSED is not abuse or neglect Alleged risk 46

  47. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts “The facility must provide each resident with sufficient fluid intake to maintain proper hydration and health.” 42 C.F.R. 483.25(j) Tag F0327 47

  48. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts 48

  49. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Tag 242 Over -treatment just as risky as under-treatment 49

  50. Hastening Death by VSED - 10-14-2016 Keynote Presentation - Legal - Pope - PowerPoint Handouts Bucilla Stephenson Now leave contemporaneous VSED 50

Recommend

Disclosures I have no disclosures 2 1 12/13/19 ARS Question Which resistance test do you

Disclosures I have no disclosures 2 1 12/13/19 ARS Question Which resistance test do you

12/13/19 Introduction to ARV Drug Resistance New Clinicians Workshop Medical Management of HIV and Hepatitis December 2019 Susa Coffey, MD Division of HIV, ID and Global Medicine 1 Disclosures I have no disclosures 2 1 12/13/19 ARS

561 views • 29 slides
Disclosures L. Brent Mitchell, MD Industry Disclosures Study Disclosures Guidant AVID

Disclosures L. Brent Mitchell, MD Industry Disclosures Study Disclosures Guidant AVID

Disclosures L. Brent Mitchell, MD Industry Disclosures Study Disclosures Guidant AVID Medtronic CIDS St. Jude MUSTT Cambridge Heart SCD-HeFT General Electric DINAMIT RAFT ICDs and CRTs for Dummies

805 views • 43 slides
Intracerebral Hemorrhage No relevant disclosures Non-related disclosures J. Claude

Intracerebral Hemorrhage No relevant disclosures Non-related disclosures J. Claude

Disclosures Intracerebral Hemorrhage No relevant disclosures Non-related disclosures J. Claude Hemphill III, MD, MAS Research Support: NIH/NINDS, Cerebrotech Stock (options): Ornim Kenneth Rainin Chair in Neurocritical Care

365 views • 8 slides
Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES EVERY CLINICIAN SHOULD KNOW

Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES EVERY CLINICIAN SHOULD KNOW

2/14/2019 Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES EVERY CLINICIAN SHOULD KNOW Felicia Chow, MD, MAS Assistant Professor University of California, San Francisco Department of Neurology and Division of Infectious

574 views • 21 slides
Disclosures I have no disclosures Nutrition & Menopause Making changes when you cant eat

Disclosures I have no disclosures Nutrition & Menopause Making changes when you cant eat

10/6/2017 Disclosures I have no disclosures Nutrition & Menopause Making changes when you cant eat like a 25 year old, and get away with it.. What changes? Mindless Eating Social situation The empty nester can lead to

340 views • 9 slides
Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES 201: BEYOND THE BASICS Felicia

Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES 201: BEYOND THE BASICS Felicia

2/13/2020 Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES 201: BEYOND THE BASICS Felicia Chow, MD, MAS Assistant Professor University of California, San Francisco Department of Neurology and Division of Infectious Diseases

611 views • 18 slides
Disclosures No financial disclosures Quantitative Evaluation of Fatty Infiltration of the

Disclosures No financial disclosures Quantitative Evaluation of Fatty Infiltration of the

5/10/2013 Disclosures No financial disclosures Quantitative Evaluation of Fatty Infiltration of the Rotator Cuff Muscles with IDEAL Magnetic Resonance Imaging Drew Lansdown, MD Lorenzo Nardo, MD Dmitrios Karampinos, PhD Julio

608 views • 4 slides
Tips and Tricks for Disclosures Laparoscopy I have no financial disclosures Jessica

Tips and Tricks for Disclosures Laparoscopy I have no financial disclosures Jessica

10/26/2016 Pushing the Envelope Tips and Tricks for Disclosures Laparoscopy I have no financial disclosures Jessica Opoku-Anane, MD, MS Assistant Professor, OB/GYN Minimally Invasive Gynecology Director, UCSF Center for Endometriosis

407 views • 8 slides
Use caution in the elderly: Disclosures review of safe and effective I have no disclosures or

Use caution in the elderly: Disclosures review of safe and effective I have no disclosures or

1/21/2018 Use caution in the elderly: Disclosures review of safe and effective I have no disclosures or conflicts of interest medication use in older patients related to this presentation John T. Holmes, PharmD, BCPS Assistant Professor

375 views • 10 slides
PQI Themes in Interior Health Disclosures No disclosures No conflict of interest

PQI Themes in Interior Health Disclosures No disclosures No conflict of interest

PQI Themes in Interior Health Disclosures No disclosures No conflict of interest Geographical and Clinical Diversity ENABLE Online Training Resources Co-Creation Dyads PQI meets MSA Overview of Physician Quality Improvement (PQI)

792 views • 62 slides
10/19/17 Disclosures I have no disclosures. Skin and Soft Tissue Infections Management of the

10/19/17 Disclosures I have no disclosures. Skin and Soft Tissue Infections Management of the

10/19/17 Disclosures I have no disclosures. Skin and Soft Tissue Infections Management of the Hospitalized Patient October 19, 2017 Jennifer Babik, MD, PhD Associate Clinical Professor Division of Infectious Diseases University of

622 views • 18 slides
Disclosures Current Issues in Practical Hematopathology: Thymomas I have no disclosures

Disclosures Current Issues in Practical Hematopathology: Thymomas I have no disclosures

Disclosures Current Issues in Practical Hematopathology: Thymomas I have no disclosures relevant and Mediastinal Lymphomas to the content of this lecture Robert P Hasserjian MD Associate Pathologist Massachusetts General Hospital

363 views • 20 slides
Disclosures Intermediate Uveitis: I have no financial disclosures When and How Do You Treat?

Disclosures Intermediate Uveitis: I have no financial disclosures When and How Do You Treat?

12/2/2016 Disclosures Intermediate Uveitis: I have no financial disclosures When and How Do You Treat? December 2, 2016 UCSF Ophthalmology Update John Gonzales, MD F.I. Proctor Foundation University of California, San Francisco Vitreous

527 views • 6 slides
DISCLOSURES Carlos Francisco Silva, MD No financial disclosures. Opinions my own. THANKS FOR

DISCLOSURES Carlos Francisco Silva, MD No financial disclosures. Opinions my own. THANKS FOR

DISCLOSURES Carlos Francisco Silva, MD No financial disclosures. Opinions my own. THANKS FOR THE INVITATION CONTENT to discuss what is value in Radiology the problem of nearly 30% of waste in imaging exams Choosing Wisely campaign and

425 views • 28 slides
Disclosures Chondrocyte Death Following Exposure to No disclosures relevant to the content

Disclosures Chondrocyte Death Following Exposure to No disclosures relevant to the content

5/10/2013 Inhibition of Disclosures Chondrocyte Death Following Exposure to No disclosures relevant to the content of this Commonly Used presentation. Anesthetics John G. Costouros, MD, Allison Rao, BS Tyler Johnston BA, MS, Alex

439 views • 4 slides
Measles Disclosures I have no disclosures Meg Fisher, MD Medical Director I may be

Measles Disclosures I have no disclosures Meg Fisher, MD Medical Director I may be

Measles Disclosures I have no disclosures Meg Fisher, MD Medical Director I may be mentioning off label uses of drugs Measles Objectives RNA virus: family Paramyxoviridae, genus Morbillivirus Recognize measles Transmitted by

341 views • 4 slides
Disclosures I have no financial disclosures to make Issues Around Periviability: What is an

Disclosures I have no financial disclosures to make Issues Around Periviability: What is an

10/15/2015 Disclosures I have no financial disclosures to make Issues Around Periviability: What is an Obstetrician to do? Melissa Rosenstein, MD, MAS University of California, San Francisco October 15, 2015 Objectives Review new

435 views • 10 slides
Disclosures I have no financial disclosures 1 5/22/2015 Case 37 y/o physician presents

Disclosures I have no financial disclosures 1 5/22/2015 Case 37 y/o physician presents

5/22/2015 Michelle Guy, MD Associate Clinical Professor UCSF Division of General Internal Medicine Primary Care of the Bariatric Surgery Patient Disclosures I have no financial disclosures 1 5/22/2015 Case 37 y/o physician presents

535 views • 20 slides
Disclosures No relevant disclosures Guidelines For Screening Although, worth mentioning:

Disclosures No relevant disclosures Guidelines For Screening Although, worth mentioning:

3/10/2017 Disclosures No relevant disclosures Guidelines For Screening Although, worth mentioning: Those at Risk of PH Limited evidence exists from formal studies on Eric D. Austin, MD, MSCI Screening in pediatric population

224 views • 11 slides
Disclosures Introduction to ARV Drug I have no disclosures Resistance New Clinicians

Disclosures Introduction to ARV Drug I have no disclosures Resistance New Clinicians

12/6/2017 Disclosures Introduction to ARV Drug I have no disclosures Resistance New Clinicians Workshop Susa Coffey, MD Division of HIV, ID and Global Medicine Introduction ARS Question Which resistance test do you order for What this

326 views • 13 slides
6/24/2019 Disclosures No disclosures Evaluating Rabies Pre exposure Prophylaxis Vaccination

6/24/2019 Disclosures No disclosures Evaluating Rabies Pre exposure Prophylaxis Vaccination

6/24/2019 Disclosures No disclosures Evaluating Rabies Pre exposure Prophylaxis Vaccination Schedules: PATRICK SOENTJENS CHIEF PHYSICIAN, POLYCLINIC, ITM, ANTWERP CHAIR, BELGIAN STUDY GROUP TRAVEL MEDICINE MED LT COL, HEAD, CENTER FOR

478 views • 13 slides
Disclosures Transforming Teaching Clinics: No financial disclosures The road to excellence

Disclosures Transforming Teaching Clinics: No financial disclosures The road to excellence

3/30/2016 Disclosures Transforming Teaching Clinics: No financial disclosures The road to excellence for primary care resident practices This research was supported by: Reena Gupta, MD Assistant Professor of Medicine Division of

419 views • 4 slides
Disclosures Updates in HIV Care I have no disclosures Susa Coffey, MD UCSF Division of HIV,

Disclosures Updates in HIV Care I have no disclosures Susa Coffey, MD UCSF Division of HIV,

6/22/2016 Disclosures Updates in HIV Care I have no disclosures Susa Coffey, MD UCSF Division of HIV, Infectious Diseases and Global Medicine San Francisco General Hospital Objectives Intro To learn about recent developments in: Why

585 views • 13 slides
Disclosures Periviable Pregnancies: Decision No financial disclosures related to this talk

Disclosures Periviable Pregnancies: Decision No financial disclosures related to this talk

Disclosures Periviable Pregnancies: Decision No financial disclosures related to this talk Making Under Uncertainty Medical Advisor to Celmatix, Mindchild Bobs Red Mill Father Aaron B. Caughey, MD, PhD Professor and Chair

395 views • 15 slides

More recommend